In the case of ALS, two key RNA processing events involving the stathmin 2 (STMN2) (Baughn et al., 2023) and UNC13A genes (Brown et al., 2022, Ma et al., 2022, Lipstein, 2022) are targets for therapeutic interventions. Here, UNC13A is linked to amyotrophic lateral sclerosis.